International Medical Innovation Award for new knee therapy
LaSalud.mx .- The therapy to treat knee osteoarthritis, developed by a team of researchers from the National Institute of Rehabilitation (INR) “Luis Guillermo Ibarra Ibarra”, won the Innovation Award 2021, awarded by the LPan American League of Rheumatology Associations (PANLAR).
The work on this new complementary treatment was titled: Viscosupplementation with Medical Grade Honey: An Innovative Approach to Treating Knee Osteoarthritis. Medical grade honey is an active biological lubricating liquid that, when injected into the joint, improves knee mobility and is helpful in restoring joint homeostasis.
The research team will work two more years in the preclinical process, as they seek to confirm the benefits of this therapy. The general director of the INR, Carlos Pineda Villasenor, declared that they want “Generate a reliable therapeutic alternative that has a positive impact on the health and quality of life of people with this disease, by providing effective and lasting symptomatic relief”.
The award consists of a financial support for 10 thousand dollars. This will be used to purchase biological reagents – such as antibodies, PCR kits, enzymes, histology reagents, and Western Blot consumables – that are required to continue the research work.
Osteoarthritis affects 10.5% of the population; it is the most common joint disease in the world and in Mexico. Among its consequences is the limitation in the daily activity of people, due to pain, stiffness and deterioration of the joints.
New therapeutic strategies are necessary, therefore, visco supplementation can become a novel complementary treatment to control progression and combat acute and conical pain caused by osteoarthritis.